Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kendra L Blalock

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Substance Use & Misuse|July 20, 2021
Staff Attitudes toward Buprenorphine before and after Implementation of an Office-Based Opioid Treatment Program in an Urban Teaching ClinicJocelyn R James, Marissa Marolf, Jared W Klein, et al.
Journal of Substance Abuse Treatment|June 7, 2021
Hepatitis C treatment outcomes among patients treated in co-located primary care and addiction treatment settingsBelle V Ngo, Jocelyn R James, Kendra L Blalock, et al.
Journal of Addiction Medicine|January 24, 2020
Acceptability and Feasibility of a Mobile Health Application for Video Directly Observed Therapy of Buprenorphine for Opioid Use Disorders in an Office-based SettingMargo E Godersky, Jared W Klein, Joseph O Merrill, et al.
Journal of Substance Abuse Treatment|October 10, 2022
Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take-home dosing during the COVID-19 pandemicKevin A Hallgren, James Darnton, Sean Soth, et al.
Addiction Science & Clinical Practice|May 25, 2023
Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort studyMary L Geist, Andrea C Radick, Judith I Tsui, et al.
Journal of General Internal Medicine|February 25, 2025
Opioid Treatment Programs and Risks for COVID-19 Infections, Emergency Visits, and HospitalizationsRyan R Cook, Kendra L Blalock, Sanae El Ibrahimi, et al.
Journal of Addiction Medicine|August 14, 2023
Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate BuprenorphineJudith I Tsui, Daniel Stephens, Brett Collins, et al.
Journal of Primary Care & Community Health|October 9, 2025
Impact of a Multi-Factorial Primary Care Intervention on Opioid Use Disorder Treatment and Overdose OutcomesAnna R Morgan-Barsamian, Sanae El Ibrahimi, Michelle A Hendricks, et al.
Substance Abuse|July 27, 2022
Peer providers and linkage with buprenorphine care after hospitalization: A retrospective cohort studyHelen E Jack, Eric D Denisiuk, Brett A Collins, et al.
Drug and Alcohol Dependence|May 7, 2023
Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugsJudith I Tsui, Paula J Lum, Lynn E Taylor, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Substance Use & Misuse|July 20, 2021
Staff Attitudes toward Buprenorphine before and after Implementation of an Office-Based Opioid Treatment Program in an Urban Teaching ClinicJocelyn R James, Marissa Marolf, Jared W Klein, et al.
Journal of Substance Abuse Treatment|June 7, 2021
Hepatitis C treatment outcomes among patients treated in co-located primary care and addiction treatment settingsBelle V Ngo, Jocelyn R James, Kendra L Blalock, et al.
Journal of Addiction Medicine|January 24, 2020
Acceptability and Feasibility of a Mobile Health Application for Video Directly Observed Therapy of Buprenorphine for Opioid Use Disorders in an Office-based SettingMargo E Godersky, Jared W Klein, Joseph O Merrill, et al.
Journal of Substance Abuse Treatment|October 10, 2022
Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take-home dosing during the COVID-19 pandemicKevin A Hallgren, James Darnton, Sean Soth, et al.
Addiction Science & Clinical Practice|May 25, 2023
Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort studyMary L Geist, Andrea C Radick, Judith I Tsui, et al.
Journal of General Internal Medicine|February 25, 2025
Opioid Treatment Programs and Risks for COVID-19 Infections, Emergency Visits, and HospitalizationsRyan R Cook, Kendra L Blalock, Sanae El Ibrahimi, et al.
Journal of Addiction Medicine|August 14, 2023
Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate BuprenorphineJudith I Tsui, Daniel Stephens, Brett Collins, et al.
Journal of Primary Care & Community Health|October 9, 2025
Impact of a Multi-Factorial Primary Care Intervention on Opioid Use Disorder Treatment and Overdose OutcomesAnna R Morgan-Barsamian, Sanae El Ibrahimi, Michelle A Hendricks, et al.
Substance Abuse|July 27, 2022
Peer providers and linkage with buprenorphine care after hospitalization: A retrospective cohort studyHelen E Jack, Eric D Denisiuk, Brett A Collins, et al.
Drug and Alcohol Dependence|May 7, 2023
Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugsJudith I Tsui, Paula J Lum, Lynn E Taylor, et al.
Pageof 2